S&P 500   4,431.85 (+2.43%)
DOW   34,725.47 (+1.65%)
QQQ   351.80 (+3.14%)
AAPL   170.33 (+6.98%)
MSFT   308.26 (+2.81%)
FB   301.71 (+2.40%)
GOOGL   2,667.02 (+3.37%)
AMZN   2,879.56 (+3.11%)
TSLA   846.35 (+2.08%)
NVDA   228.40 (+4.08%)
BABA   115.23 (+3.08%)
NIO   20.90 (-0.99%)
AMD   105.24 (+2.57%)
CGC   7.27 (+6.13%)
MU   79.27 (+0.70%)
GE   92.10 (+2.45%)
T   25.21 (+4.52%)
F   19.54 (-0.05%)
DIS   138.63 (+2.37%)
AMC   15.06 (+3.72%)
PFE   54.33 (+1.80%)
ACB   3.91 (+3.17%)
BA   190.57 (+0.43%)
S&P 500   4,431.85 (+2.43%)
DOW   34,725.47 (+1.65%)
QQQ   351.80 (+3.14%)
AAPL   170.33 (+6.98%)
MSFT   308.26 (+2.81%)
FB   301.71 (+2.40%)
GOOGL   2,667.02 (+3.37%)
AMZN   2,879.56 (+3.11%)
TSLA   846.35 (+2.08%)
NVDA   228.40 (+4.08%)
BABA   115.23 (+3.08%)
NIO   20.90 (-0.99%)
AMD   105.24 (+2.57%)
CGC   7.27 (+6.13%)
MU   79.27 (+0.70%)
GE   92.10 (+2.45%)
T   25.21 (+4.52%)
F   19.54 (-0.05%)
DIS   138.63 (+2.37%)
AMC   15.06 (+3.72%)
PFE   54.33 (+1.80%)
ACB   3.91 (+3.17%)
BA   190.57 (+0.43%)
S&P 500   4,431.85 (+2.43%)
DOW   34,725.47 (+1.65%)
QQQ   351.80 (+3.14%)
AAPL   170.33 (+6.98%)
MSFT   308.26 (+2.81%)
FB   301.71 (+2.40%)
GOOGL   2,667.02 (+3.37%)
AMZN   2,879.56 (+3.11%)
TSLA   846.35 (+2.08%)
NVDA   228.40 (+4.08%)
BABA   115.23 (+3.08%)
NIO   20.90 (-0.99%)
AMD   105.24 (+2.57%)
CGC   7.27 (+6.13%)
MU   79.27 (+0.70%)
GE   92.10 (+2.45%)
T   25.21 (+4.52%)
F   19.54 (-0.05%)
DIS   138.63 (+2.37%)
AMC   15.06 (+3.72%)
PFE   54.33 (+1.80%)
ACB   3.91 (+3.17%)
BA   190.57 (+0.43%)
S&P 500   4,431.85 (+2.43%)
DOW   34,725.47 (+1.65%)
QQQ   351.80 (+3.14%)
AAPL   170.33 (+6.98%)
MSFT   308.26 (+2.81%)
FB   301.71 (+2.40%)
GOOGL   2,667.02 (+3.37%)
AMZN   2,879.56 (+3.11%)
TSLA   846.35 (+2.08%)
NVDA   228.40 (+4.08%)
BABA   115.23 (+3.08%)
NIO   20.90 (-0.99%)
AMD   105.24 (+2.57%)
CGC   7.27 (+6.13%)
MU   79.27 (+0.70%)
GE   92.10 (+2.45%)
T   25.21 (+4.52%)
F   19.54 (-0.05%)
DIS   138.63 (+2.37%)
AMC   15.06 (+3.72%)
PFE   54.33 (+1.80%)
ACB   3.91 (+3.17%)
BA   190.57 (+0.43%)
NASDAQ:ISLE

Isleworth Healthcare Acquisition Stock Forecast, Price & News

$9.81
0.00 (0.00%)
(As of 01/28/2022 12:00 AM ET)
Add
Compare
Today's Range
$9.81
$9.83
50-Day Range
$9.81
$9.86
52-Week Range
$9.60
$9.94
Volume
12,663 shs
Average Volume
38,831 shs
Market Capitalization
$257.00 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive ISLE News and Ratings via Email

Sign-up to receive the latest news and ratings for Isleworth Healthcare Acquisition and its competitors with MarketBeat's FREE daily newsletter.


Isleworth Healthcare Acquisition logo

About Isleworth Healthcare Acquisition

Isleworth Healthcare Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in St. Petersburg, Florida.

Headlines

Isleworth Healthcare Acquisition Corp. (ISLEU)
September 19, 2021 |  nasdaq.com
Isleworth Healthcare Acquisition Corp.
August 20, 2021 |  barrons.com
See More Headlines

Industry, Sector and Symbol

Industry
Holding & other investment offices
Sub-Industry
Casinos & Gaming
Current Symbol
NASDAQ:ISLE
CUSIP
46459210
Fax
N/A
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
16,185,000
Market Cap
$257.00 million
Optionable
Not Optionable

Company Calendar

Last Earnings
8/30/2016
Today
1/28/2022
Fiscal Year End
12/31/2022

MarketRank

Overall MarketRank

1.47 out of 5 stars

Unclassified Sector

39th out of 637 stocks

Holding & Other Investment Offices Industry

48th out of 594 stocks

Analyst Opinion: 0.0Community Rank: 4.0Dividend Strength: 0.0Insider Behavior: 3.3Valuation: 0.0 5 -4 -3 -2 -1 -












Isleworth Healthcare Acquisition (NASDAQ:ISLE) Frequently Asked Questions

Are investors shorting Isleworth Healthcare Acquisition?

Isleworth Healthcare Acquisition saw a decline in short interest during the month of December. As of December 31st, there was short interest totaling 4,800 shares, a decline of 56.4% from the December 15th total of 11,000 shares. Based on an average daily volume of 21,800 shares, the days-to-cover ratio is currently 0.2 days. Approximately 0.0% of the shares of the stock are short sold.
View Isleworth Healthcare Acquisition's Short Interest
.

How were Isleworth Healthcare Acquisition's earnings last quarter?

Isleworth Healthcare Acquisition Corp. (NASDAQ:ISLE) issued its quarterly earnings results on Tuesday, August, 30th. The company reported $0.26 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $0.30 by $0.04. The business had revenue of $240.86 million for the quarter, compared to the consensus estimate of $246.88 million. Isleworth Healthcare Acquisition's revenue for the quarter was down 2.5% on a year-over-year basis. During the same period in the prior year, the business posted $0.28 EPS.
View Isleworth Healthcare Acquisition's earnings history
.

Who are Isleworth Healthcare Acquisition's key executives?

Isleworth Healthcare Acquisition's management team includes the following people:
  • Mr. Robert S. Whitehead, CEO & Director (Age 70)
  • Mr. Danny Lynn Halvorson, CFO, Exec. VP & Director (Age 55)

What other stocks do shareholders of Isleworth Healthcare Acquisition own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Isleworth Healthcare Acquisition investors own include Century Casinos (CNTY), Broadcom (AVGO), DDR (DDR), Eldorado Resorts (ERI), ImageWare Systems (IWSY), Netflix (NFLX), PayPal (PYPL), Ashford Hospitality Trust (AHT), Barings Global Short Duration High Yield Fund (BGH) and Biogen (BIIB).

What is Isleworth Healthcare Acquisition's stock symbol?

Isleworth Healthcare Acquisition trades on the NASDAQ under the ticker symbol "ISLE."

Who are Isleworth Healthcare Acquisition's major shareholders?

Isleworth Healthcare Acquisition's stock is owned by many different institutional and retail investors. Top institutional investors include Tuttle Capital Management LLC (0.29%) and Cantor Fitzgerald Investment Adviser L.P. (0.25%).
View institutional ownership trends for Isleworth Healthcare Acquisition
.

Which institutional investors are selling Isleworth Healthcare Acquisition stock?

ISLE stock was sold by a variety of institutional investors in the last quarter, including Tuttle Capital Management LLC.
View insider buying and selling activity for Isleworth Healthcare Acquisition
or view top insider-selling stocks.

Which institutional investors are buying Isleworth Healthcare Acquisition stock?

ISLE stock was purchased by a variety of institutional investors in the last quarter, including Cantor Fitzgerald Investment Adviser L.P..
View insider buying and selling activity for Isleworth Healthcare Acquisition
or or view top insider-buying stocks.

How do I buy shares of Isleworth Healthcare Acquisition?

Shares of ISLE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Isleworth Healthcare Acquisition's stock price today?

One share of ISLE stock can currently be purchased for approximately $9.81.

How much money does Isleworth Healthcare Acquisition make?

Isleworth Healthcare Acquisition has a market capitalization of $257.00 million.

What is Isleworth Healthcare Acquisition's official website?

The official website for Isleworth Healthcare Acquisition is isleofcapricasinos.com.

Where are Isleworth Healthcare Acquisition's headquarters?

Isleworth Healthcare Acquisition is headquartered at 600 Emerson Rd Ste 300, ST. LOUIS, MO 63141-6762, United States.

How can I contact Isleworth Healthcare Acquisition?

Isleworth Healthcare Acquisition's mailing address is 600 Emerson Rd Ste 300, ST. LOUIS, MO 63141-6762, United States. The company can be reached via phone at 727-245-0146.


This page was last updated on 1/28/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.